FDA
FDA Announces Determination of Regulatory Review Period for MONOFERRIC Patent Extension
The U.S. Food and Drug Administration has issued a notice stating that it has determined the regulatory review period for the drug MONOFERRIC, as required by law for a pending patent extension application submitted to…
1 source3 claims checked5h ago
3 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis